Stay updated on ARO-APOC3 in Mixed Dyslipidemia Clinical Trial
Sign up to get notified when there's something new on the ARO-APOC3 in Mixed Dyslipidemia Clinical Trial page.

Latest updates to the ARO-APOC3 in Mixed Dyslipidemia Clinical Trial page
- Check3 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check10 days agoChange DetectedAdded a 'Show glossary' option and labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with revision 3.4.0; removed the older labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' with revision 3.3.4.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page adds a consolidated Locations section listing sites across multiple regions/countries (CA, FL, GA, NV, NY, OH, SC, TX, QLD, SA, VIC, WA, ON, QC) and includes Revision: v3.3.3; prior region-specific location pages have been removed.SummaryDifference1%

- Check74 days agoChange DetectedUpdated the Publications section wording to specify that PubMed-listed publications are auto-filled from PubMed. Replaced the old description with a new version note: v3.3.2 (from v3.2.0).SummaryDifference0.1%

- Check81 days agoChange DetectedA notice about potential data delays due to government funding has been removed from the page.SummaryDifference0.3%

Stay in the know with updates to ARO-APOC3 in Mixed Dyslipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in Mixed Dyslipidemia Clinical Trial page.